Research and Development

NICE has rejected GSK's breast cancer drug Tyverb, despite an offer from the company to cut the cost of treatment. …

President Barack Obama has reiterated his aim of bringing universal healthcare to the US and has put a $76.8 billion …

AstraZeneca's respiratory drug Symbicort can be used to help US patients with chronic obstructive pulmonary disease (COPD). The FDA has …

Vidaza, an innovative new treatment for a number of hard-to-treat blood cancers, has been launched in the UK by Celgene. …

Bayer Schering Pharma's plan to build a 100 million-euro R&D centre in Beijing marks the company's first major foray into …

Novartis has recalled UK supplies of its meningitis C vaccine after tests found some batches contaminated with bacteria. The recall …

The pharma industry's current sales and marketing model will be defunct in the next ten years. That is the stark …

Lilly and Daiichi Sankyo have won European approval for their blood-thinning drug Efient, which will go up against established blockbuster …

Biologics company NovaBiotics has been dubbed a Rising Star for 2009 by the Scottish arm of the BioIndustry Association. The …

With the election of Barack Obama, widespread changes are anticipated for US healthcare and ultimately for the pharmaceutical industry. Although …

The world is getting bigger and smaller at the same time. When the internet began to really catch on about …

Psoriasis treatment Raptiva is to be suspended from use in the European Union because of concerns about rare but serious …

Servier has claimed victory in the first round of its legal battle against NICE's guidelines on osteoporosis.A judicial review requested …